The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF). (Q37561170)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF). |
scientific article |
Statements
The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF) (English)
Ruben Mesa
Alessandro M Vannucchi
Abdulraheem Yacoub
Mamta Garg
Roger Lyons
Ciro Rinaldi
Yasmin Hasan
Francesco Passamonti
Deborah Hunter
Mark M Jones
Huiling Zhen
Dany Habr
Bruno Martino
8 November 2016
1 reference